Vaccinex, Inc. SEC filings VCNX
Vaccinex, Inc. has 475 filings in SEC EDGAR's recent list, going back to Nov 12, 2002. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Mar 19, 2025 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Apr 1, 2025 | Mar 31, 2025 |
| 15-12G | Deregistration | Mar 27, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| S-8 POS | Filing | Mar 25, 2025 | — |
| S-8 POS | Filing | Mar 25, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2025 | Mar 18, 2025 |
| 25 | Filing | Mar 17, 2025 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Mar 7, 2025 | Mar 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Listing notice, Other events
|
Dec 17, 2024 | Dec 16, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 18, 2024 | — |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 14, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 424B3 | Prospectus | Oct 25, 2024 | — |
| EFFECT | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 22, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2024 | — |
| S-3 | Shelf registration | Oct 16, 2024 | — |
| 8-K |
Current report
Listing notice
|
Oct 9, 2024 | Oct 7, 2024 |
| D | Filing | Sep 27, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 20, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 20, 2024 | — |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 19, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Other events
|
Aug 20, 2024 | Aug 20, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 9, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 7, 2024 | — |
| 4 | Insider transaction | Aug 7, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Aug 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 1, 2024 | — |
| 4 | Insider transaction | Aug 1, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Other events
|
Jul 31, 2024 | Jul 31, 2024 |
| 424B3 | Prospectus | Jul 8, 2024 | — |
| EFFECT | Filing | Jul 5, 2024 | — |
| CORRESP | Letter to the SEC | Jul 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2024 | — |
| S-3 | Shelf registration | Jun 27, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 4/A | Amended statement of changes in beneficial ownership of securities | May 14, 2024 | Mar 21, 2024 |
| 4/A | Amended statement of changes in beneficial ownership of securities | May 14, 2024 | Mar 21, 2024 |
| 4/A | Amended statement of changes in beneficial ownership of securities | May 14, 2024 | Mar 21, 2024 |
| 4/A | Amended statement of changes in beneficial ownership of securities | May 14, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | May 8, 2024 | — |
| S-3/A | Filing | May 8, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| UPLOAD | Letter from the SEC | May 2, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| 10-K/A | Amended annual report | Apr 25, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Apr 22, 2024 | Apr 19, 2024 |
| EFFECT | Filing | Apr 16, 2024 | — |
| 424B3 | Prospectus | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| 8-K |
Current report
Listing notice
|
Apr 12, 2024 | Apr 11, 2024 |
| D | Filing | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 2, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 2, 2024 | May 9, 2024 |
| S-3 | Shelf registration | Apr 2, 2024 | — |
| 10-K | Annual report | Apr 2, 2024 | Dec 31, 2023 |
| NT 10-K | Filing | Apr 2, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Apr 1, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
| 3 | Initial insider ownership | Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 15, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Feb 13, 2024 | Feb 8, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 13, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 12, 2024 | — |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| 8-K/A | Amended current report | Feb 8, 2024 | Feb 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 7, 2024 | Feb 6, 2024 |
| EFFECT | Filing | Jan 19, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| S-3 | Shelf registration | Jan 10, 2024 | — |
| DEF 14A | Proxy statement | Jan 8, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Dec 28, 2023 | Dec 26, 2023 |
| PRE 14A | Preliminary proxy statement | Dec 28, 2023 | Feb 8, 2024 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 8, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 25, 2023 | Oct 23, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 18, 2023 | — |
| 8-K |
Current report
Listing notice, Other events
|
Oct 13, 2023 | Oct 10, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 12, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Oct 11, 2023 | — |
| 4 | Insider transaction | Oct 5, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2023 | Sep 28, 2023 |
| 424B4 | Prospectus | Oct 2, 2023 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| S-1MEF | Filing | Sep 28, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2023 | Sep 27, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 26, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2023 | Sep 26, 2023 |
| S-1/A | Amended registration statement | Sep 26, 2023 | — |
| 4 | Insider transaction | Sep 25, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 22, 2023 | Sep 20, 2023 |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| S-1 | Registration statement | Sep 14, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 13, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 22, 2023 | Aug 18, 2023 |
| DEF 14A | Proxy statement | Aug 14, 2023 | Sep 8, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 4, 2023 | Sep 8, 2023 |
| 424B3 | Prospectus | Jul 11, 2023 | — |
| EFFECT | Filing | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2023 | — |
| S-3 | Shelf registration | Jun 14, 2023 | — |
| 8-K |
Current report
Listing notice
|
May 30, 2023 | May 25, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | May 25, 2023 | — |
| 8-K |
Current report
Other events
|
May 19, 2023 | May 19, 2023 |
| 424B5 | Prospectus supplement | May 19, 2023 | — |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 15, 2023 | May 12, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 11, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 11, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 11, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2023 | May 11, 2023 |
| EFFECT | Filing | Apr 12, 2023 | — |
| CORRESP | Letter to the SEC | Apr 10, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| ARS | Annual report to shareholders | Apr 6, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 6, 2023 | May 11, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 5, 2023 | — |
| 4 | Insider transaction | Apr 3, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 3, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 3, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 3, 2023 | Mar 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCNX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1205922
- Former names
- VACCINEX INC (until May 9, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.